Connecting you to content on EBSCOhost

Works matching IS 20406207 AND DT 2014 AND VI 5 AND IP 4

Results: 2

1

Bruton's tyrosine kinase inhibitors and their clinical potential in the treatment of B-cell malignancies: focus on ibrutinib.

Published in:

Therapeutic Advances in Hematology, 2014, v. 5, n. 4, p. 121, doi. 10.1177/2040620714539906

By:

Aalipour, Amin;
Advani, Ranjana H.

Publication type:

Article

2

Practical management of patients with chronic myeloid leukemia who develop tyrosine kinase inhibitor-resistant BCR-ABL1 mutations.

Published in:

Therapeutic Advances in Hematology, 2014, v. 5, n. 4, p. 107, doi. 10.1177/2040620714537865

By:

Jing Ai;
Tiu, Ramon V.

Publication type:

Article